Literature DB >> 11056310

Identification of women at high risk of developing endometrial cancer on tamoxifen.

M Berlière1, G Radikov, C Galant, P Piette, E Marbaix, J Donnez.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11056310     DOI： 10.1016/s0959-8049(00)00217-3

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0959-8049            Impact factor:   9.162


× No keyword cloud information.
  5 in total

1.  Utilization of gynecologic services in women with breast cancer receiving hormonal therapy.

Authors:  Jason D Wright; Vrunda B Desai; Ling Chen; William M Burke; Ana I Tergas; June Y Hou; Melissa Accordino; Cande V Ananth; Alfred I Neugut; Dawn L Hershman
Journal:  Am J Obstet Gynecol       Date:  2017-03-21       Impact factor: 8.661

Review 2.  Clinical problem solving: utility of sonography in oncologic patients.

Authors:  Christine Cooley; Mizuki Nishino; Jyothi Jagannathan; Nikhil Ramaiya; Donald Di Salvo; Katherine M Krajewski
Journal:  J Ultrasound Med       Date:  2014-01       Impact factor: 2.153

3.  Effects of estradiol and tamoxifen on proliferation of human breast cancer cells and human endometrial cells.

Authors:  Bo Zhang; Daoda Chen; Guobin Wang; Yihua Wu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2003

4.  Endometrial adenocarcinoma in a 27-year-old woman.

Authors:  Anis Fadhlaoui; Jamel Ben Hassouna; Mohamed Khrouf; Fethi Zhioua; Anis Chaker
Journal:  Clin Med Insights Case Rep       Date:  2010-08-12

5.  Tumorigenic effects of tamoxifen on the female genital tract.

Authors:  Kaei Nasu; Noriyuki Takai; Masakazu Nishida; Hisashi Narahara
Journal:  Clin Med Pathol       Date:  2008-03-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.